Skip to main content
. 2016 Apr 18;2016(4):CD009747. doi: 10.1002/14651858.CD009747.pub2

Pereira 2014.

Methods Design: randomised controlled trial
Randomisation: individual
Trial: daily oral iron versus placebo
Date of study: not stated
Participants Setting: King's College, London, United Kingdom.
Malaria endemicity: not stated
Included: 20 healthy participants, 7 men and 13 women aged 18 to 65 years (mean age 32 years)
Excluded: chronic disease, pregnancy or lactation
Dropouts: reports no loss to follow‐up
Sample size: total: 13; intervention: 7, control: 6
Interventions Intervention: ferrous sulphate 200 mg (65 mg of elemental iron), twice a day
Control: placebo
Duration: 7 days
Outcomes Side effects
Notes Compliance: not stated
Conflicts of interest: authors declare no conflict of interest
Funded by: United Kingdom Medical Research Council
Other notes: data for women only, provided by authors via email
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Random sequence generation
Allocation concealment (selection bias) Low risk Reported allocation concealment
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Placebo
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk SEs unlikely to be affected
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No losses to follow‐up
Selective reporting (reporting bias) Low risk Not evident
Other bias Low risk Not evident